Brief: Cullinan Oncology Reports Q3 2022 Financial Results

Cullinan Therapeutics

14/11/2022 13:19

Nov 14 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
THIRD
QUARTER 2022 FINANCIAL RESULTS
    * CASH AND INVESTMENTS $606.7 MILLION AS OF SEPTEMBER 30
    * QTRLY LOSS PER SHARE $0.54

Source text for Eikon:  ID:nGNXbzYP5p 
Further company coverage:  CGEM.O 
 ((Reuters.Briefs@thomsonreuters.com;))